These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 37242690)
21. A Review on Physicochemical Properties of Polymers Used as Filaments in 3D-Printed Tablets. Doolaanea A; Latif N; Singh S; Kumar M; Safa'at MF; Alfatama M; Edros R; Bhatia A AAPS PharmSciTech; 2023 May; 24(5):116. PubMed ID: 37160772 [TBL] [Abstract][Full Text] [Related]
22. Redispersible 3D printed nanomedicines: An original application of the semisolid extrusion technique. de Oliveira TV; de Oliveira RS; Dos Santos J; Funk NL; Petzhold CL; Beck RCR Int J Pharm; 2022 Aug; 624():122029. PubMed ID: 35853566 [TBL] [Abstract][Full Text] [Related]
23. 3D-Printed Fast-Dissolving Oral Dosage Forms via Fused Deposition Modeling Based on Sugar Alcohol and Poly(Vinyl Alcohol)-Preparation, Drug Release Studies and In Vivo Oral Absorption. Ikeda S; Kobayashi M; Aoki S; Terukina T; Kanazawa T; Kojima H; Kondo H Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839717 [TBL] [Abstract][Full Text] [Related]
24. 3D Printing Technology: A New Milestone in the Development of Pharmaceuticals. Chandekar A; Mishra DK; Sharma S; Saraogi GK; Gupta U; Gupta G Curr Pharm Des; 2019; 25(9):937-945. PubMed ID: 31339069 [TBL] [Abstract][Full Text] [Related]
25. 3D Printing Technology in Drug Delivery: Recent Progress and Application. Kotta S; Nair A; Alsabeelah N Curr Pharm Des; 2018; 24(42):5039-5048. PubMed ID: 30520368 [TBL] [Abstract][Full Text] [Related]
26. 3D printed drug delivery devices: perspectives and technical challenges. Palo M; Holländer J; Suominen J; Yliruusi J; Sandler N Expert Rev Med Devices; 2017 Sep; 14(9):685-696. PubMed ID: 28774216 [TBL] [Abstract][Full Text] [Related]
27. 3D Printing Technology in Customized Drug Delivery System: Current State of the Art, Prospective and the Challenges. Khan FA; Narasimhan K; Swathi CSV; Mustak S; Mustafa G; Ahmad MZ; Akhter S Curr Pharm Des; 2018; 24(42):5049-5061. PubMed ID: 30636582 [TBL] [Abstract][Full Text] [Related]
29. Coupling hot melt extrusion and fused deposition modeling: Critical properties for successful performance. Bandari S; Nyavanandi D; Dumpa N; Repka MA Adv Drug Deliv Rev; 2021 May; 172():52-63. PubMed ID: 33571550 [TBL] [Abstract][Full Text] [Related]
30. 3D-Printing with precise layer-wise dose adjustments for paediatric use via pressure-assisted microsyringe printing. El Aita I; Rahman J; Breitkreutz J; Quodbach J Eur J Pharm Biopharm; 2020 Dec; 157():59-65. PubMed ID: 33022389 [TBL] [Abstract][Full Text] [Related]
31. Influence of the geometry of 3D printed solid oral dosage forms on their swallowability. Bogdahn M; Torner J; Krause J; Grimm M; Weitschies W Eur J Pharm Biopharm; 2021 Oct; 167():65-72. PubMed ID: 34298113 [TBL] [Abstract][Full Text] [Related]
32. Investigation of semi-solid formulations for 3D printing of drugs after prolonged storage to mimic real-life applications. Aita IE; Breitkreutz J; Quodbach J Eur J Pharm Sci; 2020 Apr; 146():105266. PubMed ID: 32060006 [TBL] [Abstract][Full Text] [Related]
33. 3D-printing of solid lipid tablets from emulsion gels. Johannesson J; Khan J; Hubert M; Teleki A; Bergström CAS Int J Pharm; 2021 Mar; 597():120304. PubMed ID: 33540029 [TBL] [Abstract][Full Text] [Related]
34. 3D printed spherical mini-tablets: Geometry versus composition effects in controlling dissolution from personalised solid dosage forms. Ayyoubi S; Cerda JR; Fernández-García R; Knief P; Lalatsa A; Healy AM; Serrano DR Int J Pharm; 2021 Mar; 597():120336. PubMed ID: 33545280 [TBL] [Abstract][Full Text] [Related]
35. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS. Oladeji S; Mohylyuk V; Jones DS; Andrews GP Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354 [TBL] [Abstract][Full Text] [Related]
36. Immediate release 3D printed oral dosage forms: How different polymers have been explored to reach suitable drug release behaviour. Funk NL; Fantaus S; Beck RCR Int J Pharm; 2022 Sep; 625():122066. PubMed ID: 35926751 [TBL] [Abstract][Full Text] [Related]
37. Quality of FDM 3D Printed Medicines for Pediatrics: Considerations for Formulation Development, Filament Extrusion, Printing Process and Printer Design. Quodbach J; Bogdahn M; Breitkreutz J; Chamberlain R; Eggenreich K; Elia AG; Gottschalk N; Gunkel-Grabole G; Hoffmann L; Kapote D; Kipping T; Klinken S; Loose F; Marquetant T; Windolf H; Geißler S; Spitz T Ther Innov Regul Sci; 2022 Nov; 56(6):910-928. PubMed ID: 34826120 [TBL] [Abstract][Full Text] [Related]
38. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing. Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102 [TBL] [Abstract][Full Text] [Related]
39. Investigation of the degradation and in-situ amorphization of the enantiomeric drug escitalopram oxalate during Fused Deposition Modeling (FDM) 3D printing. Hoffmann L; Breitkreutz J; Quodbach J Eur J Pharm Sci; 2023 Jun; 185():106423. PubMed ID: 36918059 [TBL] [Abstract][Full Text] [Related]
40. 3D Printing as a Promising Tool in Personalized Medicine. Vaz VM; Kumar L AAPS PharmSciTech; 2021 Jan; 22(1):49. PubMed ID: 33458797 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]